|
|
|
|
| LEADER |
01562nam a22003375i 4500 |
| 001 |
000289244 |
| 005 |
20210526151107.0 |
| 007 |
cr nn 008mamaa |
| 008 |
101118s2010 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642167584
|
| 024 |
7 |
|
|a 10.1007/978-3-642-16758-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Neurodegenerative Diseases /
|c edited by Celia Dominguez.
|
| 250 |
|
|
|a 1st ed. 2010.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2010.
|
| 300 |
|
|
|a XVII, 196 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Topics in Medicinal Chemistry,
|v 6
|
| 505 |
0 |
|
|a The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach -- Phosphodiesterase Inhibition to Target the Synaptic Dysfunction in Alzheimer’s Disease -- Glutamate and Neurodegenerative Disease -- Modulation of the Kynurenine Pathway for the Potential Treatment of Neurodegenerative Diseases -- Spinal Muscular Atrophy: Current Therapeutic Strategies.
|
| 650 |
|
0 |
|a Medicinal chemistry.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
1 |
4 |
|a Medicinal Chemistry.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 700 |
1 |
|
|a Dominguez, Celia.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|